Characterization of viability, scarring and hibernation of the myocardium supplied by epicardial coronary arteries with low flow grades

Objective The aim of this study was to analyse the relationship between reduced coronary artery flow and myocardial viability, scarring and hibernation. Patients and methods Coronary flow grades and collateral vessels were scored using the thrombolysis in myocardial infarction trial (TIMI) and the Rentrop and Cohen scoring systems, respectively. 13N-ammonia and fluorine-18-fluorodeoxyglucose (18F-FDG) are the perfusion and metabolic markers on PET, respectively. The left ventricle was divided into three coronary territories. The area with the highest 13N-ammonia uptake was considered the reference region. Myocardial regions with 18F-FDG uptake of at least 50% of the reference region were considered viable and those with 18F-FDG uptake less than 50% of the reference region were considered scarred. Hibernation was considered present if the viable myocardium had significant wall motion abnormality. Results There were 80 (71 males) patients with 240 myocardial territories. TIMI 2–3 arteries supplied 151 regions (group A), and 89 regions were supplied by TIMI 0–1 arteries (group B). Viable myocardium was present in 140 (93%) regions of group A and in 76 (85%) regions of group B (P=0.068). Scarring was present in 40 (26%) regions in group A and in 49 (55%) regions in group B (P<0.0001). Wall motion data were available in 215 regions: 133 regions in group A and 82 regions in group B. Hibernating myocardium was predicted in 36 (28%) regions in group A and in 34 (41%) regions in group B (P<0.05). Conclusion Myocardial regions supplied by arteries with TIMI 0–1 are characterized by significantly increased incidence of hibernation and scarring. Video abstract: http://links.lww.com/NMC/A115

[1]  H. S. Mueller,et al.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.

[2]  M Schwaiger,et al.  Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. , 1986, The New England journal of medicine.

[3]  M. Cohen,et al.  Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study. , 1986, Circulation.

[4]  S. Rahimtoola,et al.  The hibernating myocardium. , 1989, American heart journal.

[5]  M. Schwaiger,et al.  Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. , 1992, Journal of the American College of Cardiology.

[6]  W. J. Maclntyre,et al.  Metabolic Responses of Hibernating and Infarcted Myocardium to Revascularization: A Follow‐up Study of Regional Perfusion, Function, and Metabolism , 1992, Circulation.

[7]  H. Schelbert,et al.  Myocardial viability in asynergic regions subtended by occluded coronary arteries: relation to the status of collateral flow in patients with chronic coronary artery disease. , 1994, Journal of the American College of Cardiology.

[8]  S. Walton,et al.  Incidence of hibernating myocardium after acute myocardial infarction treated with thrombolysis. , 1996, Heart.

[9]  K. Beatt,et al.  Significance of the Thrombolysis in Myocardial Infarction scoring system in assessing infarct-related artery reperfusion and mortality rates after acute myocardial infarction. , 1997, American heart journal.

[10]  F. Fazio,et al.  Myocardial viability assessed with fluorodeoxyglucose and PET in patients with Q wave myocardial infarction receiving thrombolysis: relationship to coronary anatomy and ventricular function. , 1997, Nuclear medicine communications.

[11]  O. Rimoldi,et al.  Myocardial hibernation vs repetitive stunning in patients. , 1999, Cardiology in review.

[12]  S. Walton,et al.  Can the surface electrocardiogram be used to predict myocardial viability? , 1999, Heart.

[13]  P. Camici,et al.  Prevalence of hibernating myocardium in patients with severely impaired ischaemic left ventricles , 1999, Heart.

[14]  O. Simonetti,et al.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. , 1999, Circulation.

[15]  P. Camici,et al.  Efficacy of coronary angioplasty for the treatment of hibernating myocardium , 1999, Heart.

[16]  D. Warltier,et al.  Mechanisms of postischemic contractile dysfunction. , 1999, The Annals of thoracic surgery.

[17]  S G Thompson,et al.  Survival of patients with a new diagnosis of heart failure: a population based study , 2000, Heart.

[18]  T W Redpath,et al.  Regional myocardial wall thickening assessed at rest by ECG gated (18)F-FDG positron emission tomography and by magnetic resonance imaging. , 2000, Heart.

[19]  J J Bax,et al.  Positron emission tomography using(18)F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community Concerted Action Multicenter study on use of(18)F-fluoro-de , 2001, European heart journal.

[20]  Takahiro Higuchi,et al.  Cardiac positron emission tomography. , 2009, Journal of the American College of Cardiology.

[21]  C. O'connor,et al.  Coronary-artery bypass surgery in patients with left ventricular dysfunction. , 2011, The New England journal of medicine.

[22]  T. Peters,et al.  Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial. , 2014, Health technology assessment.

[23]  P. Thokala,et al.  Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy. , 2014, Health technology assessment.

[24]  D. Berman,et al.  Myocardial viability and impact of surgical ventricular reconstruction on outcomes of patients with severe left ventricular dysfunction undergoing coronary artery bypass surgery: results of the Surgical Treatment for Ischemic Heart Failure trial. , 2014, The Journal of thoracic and cardiovascular surgery.

[25]  J. Rouleau,et al.  Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. , 2016, The New England journal of medicine.